Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial

被引:0
作者
Pauline Byakika-Kibwika
Patience Nyakato
Mohammed Lamorde
Agnes N. Kiragga
机构
[1] Makerere University,Department of Medicine, College of Health Sciences
[2] Infectious Diseases Institute,undefined
来源
Malaria Journal | / 17卷
关键词
Artesunate; ACT; Malaria; Parasite clearance;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 117 条
[1]  
Erdman LK(2011)Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control study PLoS ONE 6 e17440-828
[2]  
Dhabangi A(2000)Is there any artemisinin resistance in falciparum malaria? Southeast Asian J Trop Med Public Health 31 825-280
[3]  
Musoke C(2017)Malaria parasite clearance Malar J. 16 88-550
[4]  
Conroy AL(2010)Artemisinin resistance: current status and scenarios for containment Nat Rev Microbiol 8 272-501
[5]  
Hawkes M(2013)Risk factors of shock in severe falciparum malaria Southeast Asian J Trop Med Public Health 44 541-797
[6]  
Higgins S(2011)Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator Malar J. 10 339-912
[7]  
Treeprasertsuk S(2015)Duration of residency in a non-endemic area and risk of severe malaria in African immigrants Clin Microbiol Infect 21 494-423
[8]  
Viriyavejakul P(2003)Adult Javanese migrants to Indonesian Papua at high risk of severe disease caused by malaria Epidemiol Infect 131 791-725
[9]  
Silachamroon U(2015)Parasite clearance after malaria therapy: staying a step ahead of drug resistance BMC Med. 13 251-621
[10]  
Vannphan S(2017)Intravenous artesunate plus Artemisinin based Combination Therapy (ACT) or intravenous quinine plus ACT for treatment of severe malaria in Ugandan children: a randomized controlled clinical trial BMC Infect Dis 17 794-827